IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Innate Pharma SA Class A - F s

CUSIP: F5277D100 | 2 institutional holders

Quarters

Q2 2018Q4 2015Q3 2015Q2 2015Q1 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

Sofinnova Investments, Inc.110,788
0.0% of portfolio›$604
StyleTurnoverLocationFiled
Sofinnova Investments, Inc.
110,788$6040.0%YieldHighMenlo Park, CA2018-11-15